Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
C$7.94
C$7.94
C$7.94
C$7.94
N/AN/A3,550 shsN/A
Ansell Limited stock logo
ANSLF
Ansell
$18.00
$18.00
$15.05
$23.42
N/AN/A700 shsN/A
Ansell Limited stock logo
ANSLY
Ansell
$79.49
$78.52
$53.43
$94.74
N/AN/A171 shs4 shs
Coloplast A/S stock logo
CLPBF
Coloplast A/S
$90.57
$98.08
$90.57
$140.32
N/AN/A269 shs860 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00%0.00%0.00%0.00%0.00%
Ansell Limited stock logo
ANSLF
Ansell
0.00%0.00%0.00%-23.04%+3.45%
Ansell Limited stock logo
ANSLY
Ansell
0.00%0.00%-0.64%-4.72%+17.44%
Coloplast A/S stock logo
CLPBF
Coloplast A/S
0.00%0.00%-6.84%-13.04%-23.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/AN/AN/AN/AN/A
Coloplast A/S stock logo
CLPBF
Coloplast A/S
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
0.00
N/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
0.00
N/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
0.00
N/AN/AN/A
Coloplast A/S stock logo
CLPBF
Coloplast A/S
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/AN/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLY
Ansell
N/AN/AN/AN/AN/AN/A
Coloplast A/S stock logo
CLPBF
Coloplast A/S
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/A0.00N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
N/A$0.3158.27N/AN/AN/AN/A8/26/2025 (Estimated)
Ansell Limited stock logo
ANSLY
Ansell
N/A$1.2464.33N/AN/AN/AN/A8/26/2025 (Estimated)
Coloplast A/S stock logo
CLPBF
Coloplast A/S
N/A$11.427.93N/AN/AN/AN/A8/19/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/AN/AN/AN/AN/A
Ansell Limited stock logo
ANSLF
Ansell
$0.402.24%N/A130.40%N/A
Ansell Limited stock logo
ANSLY
Ansell
$0.700.88%N/A56.91%N/A
Coloplast A/S stock logo
CLPBF
Coloplast A/S
$7.508.28%N/A65.69%N/A

Institutional Ownership

CompanyInstitutional Ownership
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/A
Ansell Limited stock logo
ANSLF
Ansell
38.97%
Ansell Limited stock logo
ANSLY
Ansell
0.60%
Coloplast A/S stock logo
CLPBF
Coloplast A/S
15.14%

Insider Ownership

CompanyInsider Ownership
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
N/A
Ansell Limited stock logo
ANSLF
Ansell
N/A
Ansell Limited stock logo
ANSLY
Ansell
N/A
Coloplast A/S stock logo
CLPBF
Coloplast A/S
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AddLife AB (publ) stock logo
ADDLF
AddLife AB (publ)
2,289N/AN/ANot Optionable
Ansell Limited stock logo
ANSLF
Ansell
14,000N/AN/ANot Optionable
Ansell Limited stock logo
ANSLY
Ansell
14,000N/AN/ANot Optionable
Coloplast A/S stock logo
CLPBF
Coloplast A/S
15,930N/AN/ANot Optionable

Recent News About These Companies

Coloplast A/S Revised guidance for FY 2024/25
Coloplast A/S (0QBO) Gets a Hold from Kepler Capital
Coloplast stock rises on solid Q1 results
Coloplast A/S - Interim Financial Report, Q1 2024/25
Coloplast A/s (OTC: CLPB.Y)
UBS revises Coloplast rating to 'neutral,' sees lower risk
Coloplast A/S - Decisions at the Annual General Meeting 2024
Coloplast A/S - Notice of Annual General Meeting 2024
Coloplast and Vestas grow in the third quarter
Coloplast A/S - Full-Year Financial Results 2023/24

New MarketBeat Followers Over Time

AddLife AB (publ) stock logo

AddLife AB (publ) OTCMKTS:ADDLF

C$7.94 0.00 (0.00%)
As of 06/20/2025

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Ansell stock logo

Ansell OTCMKTS:ANSLF

$18.00 0.00 (0.00%)
As of 06/27/2025

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Ansell stock logo

Ansell OTCMKTS:ANSLY

$79.49 0.00 (0.00%)
As of 06/27/2025

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Coloplast A/S stock logo

Coloplast A/S OTCMKTS:CLPBF

$90.57 0.00 (0.00%)
As of 06/26/2025

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.